X

Trial Profile

Effect of Abemaciclib on Metformin Pharmacokinetics and Iohexol Clearance

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 16 Jan 2020

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Abemaciclib (Primary) ; Iohexol; Metformin
Indications Brain cancer; Breast cancer; Cancer; Glioblastoma; Liposarcoma; Mantle-cell lymphoma; Non-small cell lung cancer; Pancreatic cancer; Solid tumours
Focus Pharmacokinetics
Sponsors Eli Lilly and Company

Most Recent Events

24 Mar 2018 Results assessing Abemaciclib's effect on metformin pharmacokinetics and on iohexol clearance presented at the 119th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics
23 Dec 2016 Status changed from recruiting to completed.
15 Sep 2016 New trial record

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com